Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jacquelyn Bainbridge

Concepts (192)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anticonvulsants
6
2020
251
1.430
Why?
Parkinson Disease
11
2024
614
1.040
Why?
Seizures
5
2017
489
0.630
Why?
Multiple Sclerosis
2
2016
434
0.580
Why?
Drug Resistant Epilepsy
1
2020
144
0.540
Why?
Education, Pharmacy
2
2017
124
0.510
Why?
Pharmacy
1
2017
32
0.500
Why?
Quality of Life
3
2020
3187
0.480
Why?
Neurology
1
2017
107
0.470
Why?
Psychotropic Drugs
1
2016
75
0.460
Why?
Antiparkinson Agents
3
2017
41
0.430
Why?
Disability Evaluation
1
2016
297
0.420
Why?
Laboratory Proficiency Testing
1
2014
9
0.420
Why?
Monitoring, Immunologic
1
2014
25
0.420
Why?
CD3 Complex
1
2014
112
0.400
Why?
CD4 Lymphocyte Count
1
2014
280
0.390
Why?
Laboratories
1
2014
109
0.390
Why?
Creatine
4
2017
63
0.390
Why?
Epilepsy
4
2020
397
0.380
Why?
Immunophenotyping
1
2014
324
0.380
Why?
4-Aminopyridine
1
2012
30
0.370
Why?
Potassium Channel Blockers
1
2012
47
0.370
Why?
Gait Disorders, Neurologic
1
2012
43
0.360
Why?
Cannabidiol
2
2024
142
0.330
Why?
Immunotherapy
1
2016
669
0.330
Why?
Dronabinol
3
2024
250
0.320
Why?
Drug Interactions
5
2016
403
0.310
Why?
Piracetam
1
2009
14
0.300
Why?
Gait
1
2012
316
0.300
Why?
Fructose
2
2008
132
0.290
Why?
Restless Legs Syndrome
3
2016
20
0.290
Why?
Clinical Trials as Topic
1
2014
1062
0.280
Why?
Monoamine Oxidase Inhibitors
1
2008
20
0.280
Why?
Monoamine Oxidase
1
2008
27
0.280
Why?
CD8-Positive T-Lymphocytes
1
2014
929
0.260
Why?
Walking
1
2012
544
0.260
Why?
CD4-Positive T-Lymphocytes
1
2014
1148
0.260
Why?
Epistaxis
1
2006
16
0.240
Why?
Caffeine
2
2017
76
0.230
Why?
Abdominal Neoplasms
1
2025
48
0.220
Why?
Cannabinoids
2
2025
181
0.220
Why?
Diabetic Neuropathies
1
2006
100
0.220
Why?
Patient Compliance
1
2009
587
0.210
Why?
Depression
3
2009
1566
0.190
Why?
Disease Progression
4
2017
2857
0.170
Why?
Pain
1
2006
787
0.160
Why?
Humans
31
2025
145625
0.160
Why?
Volatilization
1
2019
45
0.150
Why?
Nebulizers and Vaporizers
1
2019
63
0.150
Why?
Dopamine Agonists
2
2016
41
0.150
Why?
Ketosis
1
1999
12
0.150
Why?
Starvation
1
1999
21
0.150
Why?
Pharmaceutical Services
1
1999
76
0.140
Why?
HIV Infections
1
2014
3210
0.140
Why?
Cannabis
2
2023
519
0.140
Why?
Comorbidity
2
2016
1652
0.130
Why?
Dibenzazepines
1
2017
5
0.130
Why?
Severity of Illness Index
5
2017
2910
0.130
Why?
Schools, Pharmacy
1
2017
48
0.130
Why?
Practice Guidelines as Topic
2
2016
1581
0.120
Why?
Double-Blind Method
5
2024
2064
0.120
Why?
Analgesics, Opioid
1
2025
1158
0.120
Why?
Metabolic Diseases
1
2017
114
0.120
Why?
Air Pollution
1
2019
314
0.120
Why?
Female
19
2025
79080
0.120
Why?
Teratogens
1
2015
25
0.110
Why?
Contraceptives, Oral, Hormonal
1
2015
30
0.110
Why?
Drug Synergism
1
2016
353
0.110
Why?
Receptors, N-Methyl-D-Aspartate
1
2017
233
0.110
Why?
Cognition
1
2023
1286
0.110
Why?
Psychiatry
1
2017
182
0.100
Why?
Pharmacists
1
2017
260
0.100
Why?
Monitoring, Physiologic
1
2016
278
0.100
Why?
Male
15
2025
73014
0.100
Why?
Treatment Outcome
4
2024
11744
0.100
Why?
Quality Control
1
2014
162
0.100
Why?
Electrocardiography
1
2017
666
0.100
Why?
Observer Variation
1
2014
355
0.100
Why?
Lactation
1
2014
193
0.100
Why?
Combined Modality Therapy
1
2016
1269
0.090
Why?
Heart Rate
1
2017
844
0.090
Why?
Prognosis
2
2025
4331
0.090
Why?
Computer Simulation
1
2017
1014
0.090
Why?
Aged
10
2025
26251
0.090
Why?
Workflow
1
2014
181
0.090
Why?
Postoperative Complications
1
2025
2962
0.090
Why?
Specimen Handling
1
2014
178
0.090
Why?
Physical Therapy Modalities
1
2016
341
0.090
Why?
Data Interpretation, Statistical
1
2014
365
0.090
Why?
Program Development
1
2014
365
0.090
Why?
Middle Aged
13
2025
36359
0.090
Why?
Quality Indicators, Health Care
1
2014
340
0.080
Why?
Drug Costs
1
2012
115
0.080
Why?
Follow-Up Studies
3
2025
5397
0.080
Why?
Purines
1
2012
188
0.080
Why?
Aged, 80 and over
4
2015
8351
0.080
Why?
Flow Cytometry
1
2014
1160
0.080
Why?
Curriculum
1
2017
1074
0.080
Why?
Models, Statistical
1
2014
667
0.080
Why?
Program Evaluation
1
2014
945
0.080
Why?
Guideline Adherence
1
2014
585
0.070
Why?
Pregnancy Complications
1
2014
605
0.070
Why?
Epilepsies, Partial
1
2009
62
0.070
Why?
Predictive Value of Tests
1
2014
2097
0.070
Why?
Patient Selection
1
2012
720
0.070
Why?
Reproducibility of Results
2
2014
3396
0.070
Why?
Recovery of Function
1
2012
721
0.070
Why?
Pyrazoles
1
2012
516
0.070
Why?
Genetic Predisposition to Disease
1
2017
2455
0.070
Why?
Citalopram
1
2008
33
0.070
Why?
Polypharmacy
1
2009
94
0.070
Why?
Health Services
1
2008
112
0.060
Why?
Memory Disorders
1
2009
197
0.060
Why?
Mental Disorders
1
2016
1133
0.060
Why?
Time Factors
2
2017
7079
0.060
Why?
Community Pharmacy Services
1
2007
46
0.060
Why?
Accreditation
1
2007
100
0.060
Why?
Adult
8
2025
40821
0.060
Why?
Risk Assessment
1
2016
3678
0.060
Why?
Pharmacy Service, Hospital
1
2007
90
0.060
Why?
Drug Therapy, Combination
1
2008
1034
0.060
Why?
Data Collection
1
2008
647
0.060
Why?
Kidney Diseases
1
2009
427
0.060
Why?
Longitudinal Studies
3
2017
3005
0.050
Why?
Quality Improvement
1
2014
1325
0.050
Why?
Neoplasms
1
2020
2944
0.050
Why?
Physician-Patient Relations
1
2009
595
0.050
Why?
Patient Education as Topic
1
2009
769
0.050
Why?
Dose-Response Relationship, Drug
3
2017
2018
0.050
Why?
Chronic Disease
1
2009
1824
0.050
Why?
Biomarkers
1
2014
4329
0.050
Why?
Drug Administration Schedule
2
2017
782
0.040
Why?
2-Propanol
1
2019
20
0.040
Why?
Limit of Detection
1
2019
92
0.040
Why?
Food-Drug Interactions
1
1999
11
0.040
Why?
Diet, Protein-Restricted
1
1999
11
0.040
Why?
Calibration
1
2019
154
0.040
Why?
Spectrometry, Mass, Electrospray Ionization
1
2019
175
0.040
Why?
Clinical Competence
1
2007
1261
0.040
Why?
Surface Properties
1
2019
383
0.030
Why?
Dietary Carbohydrates
1
1999
145
0.030
Why?
Risk Factors
1
2012
10840
0.030
Why?
Catechol O-Methyltransferase Inhibitors
1
1997
6
0.030
Why?
Environmental Monitoring
1
2019
346
0.030
Why?
Dietary Fats
1
1999
307
0.030
Why?
Drug Evaluation, Preclinical
1
2017
195
0.030
Why?
Autonomic Nervous System
1
2017
82
0.030
Why?
Tandem Mass Spectrometry
1
2019
574
0.030
Why?
Marijuana Smoking
1
2019
248
0.030
Why?
Gene-Environment Interaction
1
2017
188
0.030
Why?
Women
1
2015
46
0.030
Why?
Hemodiafiltration
1
1995
7
0.030
Why?
Ciprofloxacin
1
1995
31
0.030
Why?
Prospective Studies
2
2025
8087
0.030
Why?
Enzyme Inhibitors
1
1997
820
0.030
Why?
Consensus
1
2016
465
0.030
Why?
Central Nervous System Stimulants
1
2015
183
0.020
Why?
Adenosine A2 Receptor Antagonists
1
2012
14
0.020
Why?
Counseling
1
2015
403
0.020
Why?
Evidence-Based Medicine
1
2016
727
0.020
Why?
Pregnancy
2
2015
7217
0.020
Why?
Radionuclide Imaging
1
2012
116
0.020
Why?
Palliative Care
1
2020
1032
0.020
Why?
Genotype
1
2017
1866
0.020
Why?
Diagnosis, Differential
1
2014
1500
0.020
Why?
Vasodilator Agents
1
2012
326
0.020
Why?
Animals
1
2012
38030
0.020
Why?
Sex Characteristics
1
2015
798
0.020
Why?
Age Factors
1
2017
3321
0.020
Why?
Polymorphism, Single Nucleotide
1
2017
2228
0.020
Why?
Exercise Test
1
2012
634
0.020
Why?
Periodicity
1
2008
57
0.020
Why?
Headache
1
2008
149
0.020
Why?
Recurrence
1
2008
1125
0.010
Why?
Pilot Projects
1
2008
1878
0.010
Why?
Young Adult
1
2015
14240
0.010
Why?
Ergolines
1
1997
3
0.010
Why?
Catechols
1
1997
14
0.010
Why?
Benzophenones
1
1997
16
0.010
Why?
Nitrophenols
1
1997
30
0.010
Why?
Benzothiazoles
1
1997
39
0.010
Why?
Retrospective Studies
1
2015
17291
0.010
Why?
Colorado
1
2007
4588
0.010
Why?
Thiazoles
1
1997
139
0.010
Why?
Receptors, Dopamine D2
1
1997
93
0.010
Why?
Nitriles
1
1997
211
0.010
Why?
Adolescent
1
2015
22451
0.010
Why?
Liver Failure
1
1995
75
0.010
Why?
Indoles
1
1997
509
0.010
Why?
Chromatography, High Pressure Liquid
1
1995
588
0.010
Why?
Critical Illness
1
1995
905
0.000
Why?
Acute Kidney Injury
1
1995
861
0.000
Why?
Bainbridge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)